{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:37:08Z","timestamp":1780364228619,"version":"3.54.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1966\/18"],"award-info":[{"award-number":["1966\/18"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08687-8","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:45:14Z","timestamp":1752137114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["cJun-N-terminal kinase activity and mitosis perturbation drive the 2-methoxyestradiol-mediated enhancement of viral oncolysis by Epizootic Hemorrhagic Disease Virus-Tel Aviv University"],"prefix":"10.1038","volume":"15","author":[{"given":"Sucheta","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomi","family":"Kashkash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Bozhdansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Bacharach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"8687_CR1","doi-asserted-by":"publisher","unstructured":"Filho, A. M. et al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int. J. Cancer https:\/\/doi.org\/10.1002\/ijc.35278","DOI":"10.1002\/ijc.35278"},{"key":"8687_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/BLC-150034","volume":"2","author":"NE Power","year":"2016","unstructured":"Power, N. E. & Izawa, J. Comparison of guidelines on non-muscle invasive bladder cancer (EAU, CUA, AUA, NCCN, NICE). Bladder Cancer. 2, 27\u201336. https:\/\/doi.org\/10.3233\/BLC-150034 (2016).","journal-title":"Bladder Cancer"},{"key":"8687_CR3","doi-asserted-by":"publisher","unstructured":"Messing, E. M., The, B. C. G. & Shortage Bladder Cancer 3, 227\u2013228 https:\/\/doi.org\/10.3233\/BLC-179018 (2017).","DOI":"10.3233\/BLC-179018"},{"key":"8687_CR4","doi-asserted-by":"publisher","unstructured":"Qu, F., Darji, S. & Thompson, D. H. Recent advances in drug delivery strategies for High-Risk BCG-Unresponsive Non-Muscle invasive bladder cancer: a brief review from 2018 to 2024. Pharmaceutics 16 https:\/\/doi.org\/10.3390\/pharmaceutics16091154 (2024).","DOI":"10.3390\/pharmaceutics16091154"},{"key":"8687_CR5","doi-asserted-by":"publisher","first-page":"e230849","DOI":"10.1001\/jamanetworkopen.2023.0849","volume":"6","author":"IM McElree","year":"2023","unstructured":"McElree, I. M., Steinberg, R. L., Mott, S. L., O\u2019Donnell, M. A. & Packiam, V. T. Comparison of sequential intravesical gemcitabine and docetaxel vs Bacillus Calmette-Guerin for the treatment of patients with high-risk non-muscle-invasive bladder cancer. JAMA Netw. Open 6, e230849. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.0849 (2023).","journal-title":"JAMA Netw. Open"},{"key":"8687_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57\u201370. https:\/\/doi.org\/10.1016\/s0092-8674(00)81683-9 (2000).","journal-title":"Cell"},{"key":"8687_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"key":"8687_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/277665a0","volume":"277","author":"PB Schiff","year":"1979","unstructured":"Schiff, P. B., Fant, J. & Horwitz, S. B. Promotion of microtubule assembly in vitro by taxol. Nature 277, 665\u2013667. https:\/\/doi.org\/10.1038\/277665a0 (1979).","journal-title":"Nature"},{"key":"8687_CR9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd3253","volume":"9","author":"C Dumontet","year":"2010","unstructured":"Dumontet, C. & Jordan, M. A. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat. Rev. Drug Discov. 9, 790\u2013803. https:\/\/doi.org\/10.1038\/nrd3253 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"8687_CR10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1091\/mbc.10.4.947","volume":"10","author":"AM Yvon","year":"1999","unstructured":"Yvon, A. M., Wadsworth, P. & Jordan, M. A. Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol. Biol. Cell. 10, 947\u2013959. https:\/\/doi.org\/10.1091\/mbc.10.4.947 (1999).","journal-title":"Mol. Biol. Cell."},{"key":"8687_CR11","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1242\/jcs.039719","volume":"122","author":"KE Gascoigne","year":"2009","unstructured":"Gascoigne, K. E. & Taylor, S. S. How do anti-mitotic drugs kill cancer cells? J. Cell Sci. 122, 2579\u20132585. https:\/\/doi.org\/10.1242\/jcs.039719 (2009).","journal-title":"J. Cell Sci."},{"key":"8687_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","volume":"13","author":"M Obeid","year":"2007","unstructured":"Obeid, M. et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13, 54\u201361. https:\/\/doi.org\/10.1038\/nm1523 (2007).","journal-title":"Nat. Med."},{"key":"8687_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/emboj.2009.1","volume":"28","author":"T Panaretakis","year":"2009","unstructured":"Panaretakis, T. et al. Mechanisms of pre-apoptotic calreticulin exposure in Immunogenic cell death. EMBO J. 28, 578\u2013590. https:\/\/doi.org\/10.1038\/emboj.2009.1 (2009).","journal-title":"EMBO J."},{"key":"8687_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-05912-0","volume":"616","author":"S Sen Santara","year":"2023","unstructured":"Sen Santara, S. et al. The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells. Nature 616, 348\u2013356. https:\/\/doi.org\/10.1038\/s41586-023-05912-0 (2023).","journal-title":"Nature"},{"key":"8687_CR15","doi-asserted-by":"publisher","first-page":"102227","DOI":"10.1016\/j.ctrv.2021.102227","volume":"101","author":"CL Gerard","year":"2021","unstructured":"Gerard, C. L. et al. Turning tumors from cold to inflamed to improve immunotherapy response. Cancer Treat. Rev. 101, 102227. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102227 (2021).","journal-title":"Cancer Treat. Rev."},{"key":"8687_CR16","doi-asserted-by":"publisher","unstructured":"Ehrlich, M. & Bacharach, E. Oncolytic virotherapy: the Cancer cell side. Cancers (Basel). 13. https:\/\/doi.org\/10.3390\/cancers13050939 (2021).","DOI":"10.3390\/cancers13050939"},{"key":"8687_CR17","first-page":"4192","volume":"14","author":"K Li","year":"2022","unstructured":"Li, K. et al. Advances in the clinical development of oncolytic viruses. Am. J. Transl. Res. 14, 4192\u20134206 (2022).","journal-title":"Am. J. Transl. Res."},{"key":"8687_CR18","doi-asserted-by":"publisher","first-page":"e2206948","DOI":"10.1002\/smll.202206948","volume":"19","author":"S Duan","year":"2023","unstructured":"Duan, S. et al. Oncolytic virus-driven biotherapies from bench to bedside. Small 19, e2206948. https:\/\/doi.org\/10.1002\/smll.202206948 (2023).","journal-title":"Small"},{"key":"8687_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","volume":"20","author":"SZ Shalhout","year":"2023","unstructured":"Shalhout, S. Z., Miller, D. M., Emerick, K. S. & Kaufman, H. L. Therapy with oncolytic viruses: progress and challenges. Nat. Rev. Clin. Oncol. 20, 160\u2013177. https:\/\/doi.org\/10.1038\/s41571-022-00719-w (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"8687_CR20","doi-asserted-by":"publisher","first-page":"52115","DOI":"10.18632\/oncotarget.10313","volume":"7","author":"O Danziger","year":"2016","unstructured":"Danziger, O., Shai, B., Sabo, Y., Bacharach, E. & Ehrlich, M. Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection. Oncotarget 7, 52115\u201352134. https:\/\/doi.org\/10.18632\/oncotarget.10313 (2016).","journal-title":"Oncotarget"},{"key":"8687_CR21","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1002\/ijc.33401","volume":"148","author":"S Dellac","year":"2021","unstructured":"Dellac, S. et al. Constitutive low expression of antiviral effectors sensitizes melanoma cells to a novel oncolytic virus. Int. J. Cancer. 148, 2321\u20132334. https:\/\/doi.org\/10.1002\/ijc.33401 (2021).","journal-title":"Int. J. Cancer"},{"key":"8687_CR22","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/sj.mt.6300193","volume":"15","author":"JA Noser","year":"2007","unstructured":"Noser, J. A. et al. The RAS\/Raf1\/MEK\/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells. Mol. Ther. 15, 1531\u20131536. https:\/\/doi.org\/10.1038\/sj.mt.6300193 (2007).","journal-title":"Mol. Ther."},{"key":"8687_CR23","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ijc.25088","volume":"127","author":"KX Zhang","year":"2010","unstructured":"Zhang, K. X. et al. Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death. Int. J. Cancer. 127, 830\u2013838. https:\/\/doi.org\/10.1002\/ijc.25088 (2010).","journal-title":"Int. J. Cancer"},{"key":"8687_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.celrep.2016.03.006","volume":"15","author":"YV Katlinskaya","year":"2016","unstructured":"Katlinskaya, Y. V. et al. Suppression of type I interferon signaling overcomes oncogene-Induced senescence and mediates melanoma development and progression. Cell. Rep. 15, 171\u2013180. https:\/\/doi.org\/10.1016\/j.celrep.2016.03.006 (2016).","journal-title":"Cell. Rep."},{"key":"8687_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ccell.2017.01.004","volume":"31","author":"KV Katlinski","year":"2017","unstructured":"Katlinski, K. V. et al. Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment. Cancer Cell. 31, 194\u2013207. https:\/\/doi.org\/10.1016\/j.ccell.2017.01.004 (2017). https:\/\/doi.org\/https:\/\/doi.org\/","journal-title":"Cancer Cell."},{"key":"8687_CR26","doi-asserted-by":"publisher","first-page":"46278","DOI":"10.1074\/jbc.M304721200","volume":"278","author":"L Klampfer","year":"2003","unstructured":"Klampfer, L. et al. Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through Inhibition of STAT1 and STAT2 expression. J. Biol. Chem. 278, 46278\u201346287. https:\/\/doi.org\/10.1074\/jbc.M304721200 (2003).","journal-title":"J. Biol. Chem."},{"key":"8687_CR27","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1038\/onc.2008.147","volume":"27","author":"KY Lee","year":"2008","unstructured":"Lee, K. Y. et al. Epigenetic disruption of interferon-\u03b3 response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Oncogene 27, 5267\u20135276. https:\/\/doi.org\/10.1038\/onc.2008.147 (2008).","journal-title":"Oncogene"},{"key":"8687_CR28","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1038\/sj.onc.1206594","volume":"22","author":"OI Kulaeva","year":"2003","unstructured":"Kulaeva, O. I. et al. Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene 22, 4118\u20134127. https:\/\/doi.org\/10.1038\/sj.onc.1206594 (2003).","journal-title":"Oncogene"},{"key":"8687_CR29","doi-asserted-by":"publisher","first-page":"e28683","DOI":"10.1371\/journal.pone.0028683","volume":"6","author":"Q Li","year":"2011","unstructured":"Li, Q. & Tainsky, M. A. Epigenetic silencing of IRF7 and\/or IRF5 in lung cancer cells leads to increased sensitivity to oncolytic viruses. PLoS One. 6, e28683. https:\/\/doi.org\/10.1371\/journal.pone.0028683 (2011).","journal-title":"PLoS One"},{"key":"8687_CR30","doi-asserted-by":"publisher","first-page":"E10981","DOI":"10.1073\/pnas.1712514114","volume":"114","author":"ML Stone","year":"2017","unstructured":"Stone, M. L. et al. Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden. Proc. Natl. Acad. Sci. USA. 114, E10981\u2013e10990. https:\/\/doi.org\/10.1073\/pnas.1712514114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8687_CR31","doi-asserted-by":"publisher","first-page":"13397","DOI":"10.1128\/JVI.02116-13","volume":"87","author":"B Shai","year":"2013","unstructured":"Shai, B. et al. Epizootic hemorrhagic disease virus induces and benefits from cell stress, autophagy, and apoptosis. J. Virol. 87, 13397\u201313408. https:\/\/doi.org\/10.1128\/JVI.02116-13 (2013).","journal-title":"J. Virol."},{"key":"8687_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fimmu.2018.00094","volume":"9","author":"O Danziger","year":"2018","unstructured":"Danziger, O., Pupko, T., Bacharach, E. & Ehrlich, M. Interleukin-6 and Interferon-alpha signaling via JAK1-STAT differentially regulate oncolytic versus cytoprotective antiviral States. Front. Immunol. 9, 94. https:\/\/doi.org\/10.3389\/fimmu.2018.00094 (2018).","journal-title":"Front. Immunol."},{"key":"8687_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1158\/2159-8290.Cd-nb2015-158","volume":"6","author":"A Poh","year":"2016","unstructured":"Poh, A. First oncolytic viral therapy for melanoma. Cancer Discov. 6, 6. https:\/\/doi.org\/10.1158\/2159-8290.Cd-nb2015-158 (2016).","journal-title":"Cancer Discov."},{"key":"8687_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40169-018-0214-5","volume":"7","author":"CJ LaRocca","year":"2018","unstructured":"LaRocca, C. J. & Warner, S. G. Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials. Clin. Transl. Med. 7, 35. https:\/\/doi.org\/10.1186\/s40169-018-0214-5 (2018).","journal-title":"Clin. Transl. Med."},{"key":"8687_CR35","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1200\/jco.2016.67.1529","volume":"34","author":"I Puzanov","year":"2016","unstructured":"Puzanov, I. et al. Talimogene laherparepvec in combination with ipilimumab in previously untreated, unresectable stage IIIB-IV melanoma. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 34, 2619\u20132626. https:\/\/doi.org\/10.1200\/jco.2016.67.1529 (2016).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"8687_CR36","doi-asserted-by":"publisher","unstructured":"Samson, A. et al. Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Sci. Transl. Med. 10 https:\/\/doi.org\/10.1126\/scitranslmed.aam7577 (2018).","DOI":"10.1126\/scitranslmed.aam7577"},{"key":"8687_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1158\/1535-7163.Mct-20-0405","volume":"20","author":"SI Kim","year":"2021","unstructured":"Kim, S. I. et al. Recombinant orthopoxvirus primes colon cancer for checkpoint inhibitor and cross-primes T cells for antitumor and antiviral immunity. Mol. Cancer Ther. 20, 173\u2013182. https:\/\/doi.org\/10.1158\/1535-7163.Mct-20-0405 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"8687_CR38","doi-asserted-by":"publisher","unstructured":"Zuo, S. et al. An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade. J. Immunother. Cancer 9 https:\/\/doi.org\/10.1136\/jitc-2021-002843 (2021).","DOI":"10.1136\/jitc-2021-002843"},{"key":"8687_CR39","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1200\/jco.22.00343","volume":"41","author":"JA Chesney","year":"2023","unstructured":"Chesney, J. A. et al. Double-blind, placebo-controlled, global phase III trial of talimogene laherparepvec combined with pembrolizumab for advanced melanoma. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 41, 528\u2013540. https:\/\/doi.org\/10.1200\/jco.22.00343 (2023). Randomized.","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"8687_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/jamaoncol.2019.6152","volume":"6","author":"CM Kelly","year":"2020","unstructured":"Kelly, C. M. et al. Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene Laherparepvec in combination with pembrolizumab: a phase 2 clinical trial. JAMA Oncol. 6, 402\u2013408. https:\/\/doi.org\/10.1001\/jamaoncol.2019.6152 (2020).","journal-title":"JAMA Oncol."},{"key":"8687_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cytogfr.2020.07.008","volume":"56","author":"VH Gilchrist","year":"2020","unstructured":"Gilchrist, V. H., J\u00e9mus-Gonzalez, E., Said, A. & Alain, T. Kinase inhibitors with viral oncolysis: unmasking pharmacoviral approaches for cancer therapy. Cytokine Growth Factor Rev. 56, 83\u201393. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.07.008 (2020).","journal-title":"Cytokine Growth Factor Rev."},{"key":"8687_CR42","doi-asserted-by":"publisher","unstructured":"De, S. & Ehrlich, M. Arrest and attack: Microtubule-Targeting agents and oncolytic viruses employ complementary mechanisms to enhance Anti-Tumor therapy efficacy. Genes (Basel). 15. https:\/\/doi.org\/10.3390\/genes15091193 (2024).","DOI":"10.3390\/genes15091193"},{"key":"8687_CR43","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1073\/pnas.91.9.3964","volume":"91","author":"RJ D\u2019Amato","year":"1994","unstructured":"D\u2019Amato, R. J., Lin, C. M., Flynn, E., Folkman, J. & Hamel, E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl. Acad. Sci. USA. 91, 3964\u20133968. https:\/\/doi.org\/10.1073\/pnas.91.9.3964 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8687_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1592\/phco.23.2.165.32088","volume":"23","author":"NJ Lakhani","year":"2003","unstructured":"Lakhani, N. J., Sarkar, M. A., Venitz, J. & Figg, W. D. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23, 165\u2013172. https:\/\/doi.org\/10.1592\/phco.23.2.165.32088 (2003).","journal-title":"Pharmacotherapy"},{"key":"8687_CR45","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/s1535-6108(03)00077-1","volume":"3","author":"NJ Mabjeesh","year":"2003","unstructured":"Mabjeesh, N. J. et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell. 3, 363\u2013375. https:\/\/doi.org\/10.1016\/s1535-6108(03)00077-1 (2003).","journal-title":"Cancer Cell."},{"key":"8687_CR46","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/sj.bjc.6601591","volume":"90","author":"CR Ireson","year":"2004","unstructured":"Ireson, C. R. et al. Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. Br. J. Cancer. 90, 932\u2013937. https:\/\/doi.org\/10.1038\/sj.bjc.6601591 (2004).","journal-title":"Br. J. Cancer"},{"key":"8687_CR47","first-page":"3983","volume":"24","author":"L Li","year":"2004","unstructured":"Li, L., Heldin, N. E., Graw\u00e9, J., Ulmsten, U. & Fu, X. Induction of apoptosis or necrosis in human endometrial carcinoma cells by 2-methoxyestradiol. Anticancer Res. 24, 3983\u20133990 (2004).","journal-title":"Anticancer Res."},{"key":"8687_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11060-004-2158-4","volume":"72","author":"K Chamaon","year":"2005","unstructured":"Chamaon, K. et al. Micromolar concentrations of 2-methoxyestradiol kill glioma cells by an apoptotic mechanism, without destroying their microtubule cytoskeleton. J. Neurooncol. 72, 11\u201316. https:\/\/doi.org\/10.1007\/s11060-004-2158-4 (2005).","journal-title":"J. Neurooncol."},{"key":"8687_CR49","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/j.1440-1746.2007.05033.x","volume":"22","author":"G Schumacher","year":"2007","unstructured":"Schumacher, G. et al. Antineoplastic activity of 2-methoxyestradiol in human pancreatic and gastric cancer cells with different multidrug-resistant phenotypes. J. Gastroenterol. Hepatol. 22, 1469\u20131473. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05033.x (2007).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"8687_CR50","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.4161\/cc.8.23.10105","volume":"8","author":"D Escuin","year":"2009","unstructured":"Escuin, D. et al. The hematopoietic-specific beta1-tubulin is naturally resistant to 2-methoxyestradiol and protects patients from drug-induced myelosuppression. Cell. Cycle. 8, 3914\u20133924. https:\/\/doi.org\/10.4161\/cc.8.23.10105 (2009).","journal-title":"Cell. Cycle"},{"key":"8687_CR51","doi-asserted-by":"publisher","first-page":"6924","DOI":"10.1158\/0008-5472.Can-09-1270","volume":"69","author":"S Lorin","year":"2009","unstructured":"Lorin, S. et al. c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated ewing sarcoma cells. Cancer Res. 69, 6924\u20136931. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-1270 (2009).","journal-title":"Cancer Res."},{"key":"8687_CR52","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.steroids.2010.02.016","volume":"75","author":"AO Mueck","year":"2010","unstructured":"Mueck, A. O. & Seeger, H. 2-Methoxyestradiol\u2014biology and mechanism of action. Steroids 75, 625\u2013631. https:\/\/doi.org\/10.1016\/j.steroids.2010.02.016 (2010). https:\/\/doi.org\/https:\/\/doi.org\/","journal-title":"Steroids"},{"key":"8687_CR53","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1074\/jbc.M110.161851","volume":"286","author":"D Chetrit","year":"2011","unstructured":"Chetrit, D. et al. Negative regulation of the endocytic adaptor disabled-2 (Dab2) in mitosis. J. Biol. Chem. 286, 5392\u20135403. https:\/\/doi.org\/10.1074\/jbc.M110.161851 (2011).","journal-title":"J. Biol. Chem."},{"key":"8687_CR54","doi-asserted-by":"publisher","first-page":"e43459","DOI":"10.1371\/journal.pone.0043459","volume":"7","author":"T Hirschhorn","year":"2012","unstructured":"Hirschhorn, T., Barizilay, L., Smorodinsky, N. I. & Ehrlich, M. Differential regulation of Smad3 and of the type II transforming growth factor-beta receptor in mitosis: implications for signaling. PLoS One 7, e43459. https:\/\/doi.org\/10.1371\/journal.pone.0043459 (2012).","journal-title":"PLoS One"},{"key":"8687_CR55","doi-asserted-by":"publisher","first-page":"e68703","DOI":"10.1371\/journal.pone.0068703","volume":"8","author":"KL Kuo","year":"2013","unstructured":"Kuo, K. L. et al. 2-methoxyestradiol induces mitotic arrest, apoptosis, and synergistic cytotoxicity with arsenic trioxide in human urothelial carcinoma cells. PLoS One 8, e68703. https:\/\/doi.org\/10.1371\/journal.pone.0068703 (2013).","journal-title":"PLoS One"},{"key":"8687_CR56","doi-asserted-by":"publisher","unstructured":"Njangiru, I. K. et al. A novel 2-Methoxyestradiol derivative: disrupting mitosis inhibiting cell motility and inducing apoptosis in HeLa cells in vitro. Pharmaceutics 16 https:\/\/doi.org\/10.3390\/pharmaceutics16050622 (2024).","DOI":"10.3390\/pharmaceutics16050622"},{"key":"8687_CR57","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1021\/mp100190f","volume":"7","author":"S Verenich","year":"2010","unstructured":"Verenich, S. & Gerk, P. M. Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges. Mol. Pharm. 7, 2030\u20132039. https:\/\/doi.org\/10.1021\/mp100190f (2010).","journal-title":"Mol. Pharm."},{"key":"8687_CR58","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4049\/immunohorizons.2200018","volume":"6","author":"M Shmerling","year":"2022","unstructured":"Shmerling, M. et al. LY6S, a new IFN-Inducible human member of the Ly6a subfamily expressed by spleen cells and associated with inflammation and viral resistance. Immunohorizons 6, 253\u2013272. https:\/\/doi.org\/10.4049\/immunohorizons.2200018 (2022).","journal-title":"Immunohorizons"},{"key":"8687_CR59","doi-asserted-by":"publisher","first-page":"151328","DOI":"10.1016\/j.ejcb.2023.151328","volume":"102","author":"L Barer","year":"2023","unstructured":"Barer, L., Schr\u00f6der, S. K., Weiskirchen, R., Bacharach, E. & Ehrlich, M. Lipocalin-2 regulates the expression of interferon-stimulated genes and the susceptibility of prostate cancer cells to oncolytic virus infection. Eur. J. Cell. Biol. 102, 151328. https:\/\/doi.org\/10.1016\/j.ejcb.2023.151328 (2023).","journal-title":"Eur. J. Cell. Biol."},{"key":"8687_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12977-015-0220-2","volume":"12","author":"E Elis","year":"2015","unstructured":"Elis, E., Ehrlich, M. & Bacharach, E. Dynamics and restriction of murine leukemia virus cores in mitotic and interphase cells. Retrovirology 12, 95. https:\/\/doi.org\/10.1186\/s12977-015-0220-2 (2015).","journal-title":"Retrovirology"},{"key":"8687_CR61","doi-asserted-by":"publisher","first-page":"e1003103","DOI":"10.1371\/journal.ppat.1003103","volume":"8","author":"E Elis","year":"2012","unstructured":"Elis, E., Ehrlich, M., Prizan-Ravid, A., Laham-Karam, N. & Bacharach, E. p12 tethers the murine leukemia virus pre-integration complex to mitotic chromosomes. PLoS Pathog. 8, e1003103. https:\/\/doi.org\/10.1371\/journal.ppat.1003103 (2012).","journal-title":"PLoS Pathog"},{"key":"8687_CR62","doi-asserted-by":"publisher","first-page":"15561","DOI":"10.1074\/jbc.M412630200","volume":"280","author":"Y Sun","year":"2005","unstructured":"Sun, Y. & Leaman, D. W. Involvement of Noxa in cellular apoptotic responses to interferon, double-stranded RNA, and virus infection. J. Biol. Chem. 280, 15561\u201315568. https:\/\/doi.org\/10.1074\/jbc.M412630200 (2005).","journal-title":"J. Biol. Chem."},{"key":"8687_CR63","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41419-021-04415-y","volume":"12","author":"G Karbon","year":"2021","unstructured":"Karbon, G. et al. The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents. Cell. Death Dis. 12, 1151. https:\/\/doi.org\/10.1038\/s41419-021-04415-y (2021).","journal-title":"Cell. Death Dis."},{"key":"8687_CR64","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1111\/j.1742-4658.2008.06349.x","volume":"275","author":"SN Kolomeichuk","year":"2008","unstructured":"Kolomeichuk, S. N., Terrano, D. T., Lyle, C. S., Sabapathy, K. & Chambers, T. C. Distinct signaling pathways of microtubule inhibitors\u2013vinblastine and taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively. Febs J. 275, 1889\u20131899. https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06349.x (2008).","journal-title":"Febs J."},{"key":"8687_CR65","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/mc.20458","volume":"48","author":"M Fukui","year":"2009","unstructured":"Fukui, M. & Zhu, B. T. Mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in human breast cancer cells. Mol. Carcinog. 48, 66\u201378. https:\/\/doi.org\/10.1002\/mc.20458 (2009).","journal-title":"Mol. Carcinog."},{"key":"8687_CR66","doi-asserted-by":"publisher","unstructured":"Chen, J. et al. The roles of c-Jun N-Terminal kinase (JNK) in infectious diseases. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22179640 (2021).","DOI":"10.3390\/ijms22179640"},{"key":"8687_CR67","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/0008-5472.Can-06-3406","volume":"67","author":"R Bhati","year":"2007","unstructured":"Bhati, R. et al. 2-methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells. Cancer Res. 67, 702\u2013708. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-3406 (2007).","journal-title":"Cancer Res."},{"key":"8687_CR68","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/j.1471-4159.2007.04652.x","volume":"102","author":"C Chen","year":"2007","unstructured":"Chen, C. et al. Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1alpha and apoptotic genes in a middle cerebral artery occlusion-induced focal ischemia rat model. J. Neurochem. 102, 1831\u20131841. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04652.x (2007).","journal-title":"J. Neurochem."},{"key":"8687_CR69","doi-asserted-by":"publisher","first-page":"10660","DOI":"10.1073\/pnas.0600447103","volume":"103","author":"LT Vassilev","year":"2006","unstructured":"Vassilev, L. T. et al. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc. Natl. Acad. Sci. USA. 103, 10660\u201310665. https:\/\/doi.org\/10.1073\/pnas.0600447103 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8687_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.virol.2007.05.043","volume":"368","author":"C Davy","year":"2007","unstructured":"Davy, C. & Doorbar, J. G2\/M cell cycle arrest in the life cycle of viruses. Virology 368, 219\u2013226. https:\/\/doi.org\/10.1016\/j.virol.2007.05.043 (2007).","journal-title":"Virology"},{"key":"8687_CR71","doi-asserted-by":"publisher","first-page":"11186","DOI":"10.1128\/jvi.77.20.11186-11192.2003","volume":"77","author":"O Planz","year":"2003","unstructured":"Planz, O. et al. Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complex. J. Virol. 77, 11186\u201311192. https:\/\/doi.org\/10.1128\/jvi.77.20.11186-11192.2003 (2003).","journal-title":"J. Virol."},{"key":"8687_CR72","doi-asserted-by":"publisher","first-page":"7555","DOI":"10.1128\/JVI.75.16.7555-7563.2001","volume":"75","author":"E Morita","year":"2001","unstructured":"Morita, E. et al. Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins. J. Virol. 75, 7555\u20137563. https:\/\/doi.org\/10.1128\/JVI.75.16.7555-7563.2001 (2001).","journal-title":"J. Virol."},{"key":"8687_CR73","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.1128\/jvi.75.16.7429-7434.2001","volume":"75","author":"GJ Poggioli","year":"2001","unstructured":"Poggioli, G. J., Dermody, T. S. & Tyler, K. L. Reovirus-induced sigma1s-dependent G(2)\/M phase cell cycle arrest is associated with Inhibition of p34(cdc2). J. Virol. 75, 7429\u20137434. https:\/\/doi.org\/10.1128\/jvi.75.16.7429-7434.2001 (2001).","journal-title":"J. Virol."},{"key":"8687_CR74","doi-asserted-by":"publisher","unstructured":"Tang, J. et al. Arrest of Cell Cycle by Avian Reovirus p17 through Its Interaction with Bub3. Viruses 14 (2022). https:\/\/doi.org\/10.3390\/v14112385","DOI":"10.3390\/v14112385"},{"key":"8687_CR75","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.7150\/ijbs.26400","volume":"14","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. Zika virus envelope protein induces G2\/M cell cycle arrest and apoptosis via an intrinsic cell death signaling pathway in neuroendocrine PC12 cells. Int. J. Biol. Sci. 14, 1099\u20131108. https:\/\/doi.org\/10.7150\/ijbs.26400 (2018).","journal-title":"Int. J. Biol. Sci."},{"key":"8687_CR76","doi-asserted-by":"publisher","unstructured":"Bressy, C., Droby, G. N., Maldonado, B. D., Steuerwald, N. & Grdzelishvili, V. Z. Cell cycle arrest in G(2)\/M phase enhances replication of interferon-sensitive cytoplasmic RNA viruses via Inhibition of antiviral gene expression. J. Virol. 93 https:\/\/doi.org\/10.1128\/jvi.01885-18 (2019).","DOI":"10.1128\/jvi.01885-18"},{"key":"8687_CR77","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1042\/bst20231071","volume":"52","author":"A Contreras","year":"2024","unstructured":"Contreras, A. & Perea-Resa, C. Transcriptional repression across mitosis: mechanisms and functions. Biochem. Soc. Trans. 52, 455\u2013464. https:\/\/doi.org\/10.1042\/bst20231071 (2024).","journal-title":"Biochem. Soc. Trans."},{"key":"8687_CR78","doi-asserted-by":"publisher","first-page":"6772","DOI":"10.1038\/s41388-021-02117-5","volume":"40","author":"L Yin","year":"2021","unstructured":"Yin, L. et al. Protein kinase RNA-activated controls mitotic progression and determines Paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer. Oncogene 40, 6772\u20136785. https:\/\/doi.org\/10.1038\/s41388-021-02117-5 (2021).","journal-title":"Oncogene"},{"key":"8687_CR79","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/6854","volume":"21","author":"A Behrens","year":"1999","unstructured":"Behrens, A., Sibilia, M. & Wagner, E. F. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat. Genet. 21, 326\u2013329. https:\/\/doi.org\/10.1038\/6854 (1999).","journal-title":"Nat. Genet."},{"key":"8687_CR80","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1126\/science.288.5467.870","volume":"288","author":"C Tournier","year":"2000","unstructured":"Tournier, C. et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science (New York N Y). 288, 870\u2013874. https:\/\/doi.org\/10.1126\/science.288.5467.870 (2000).","journal-title":"Science (New York N Y)"},{"key":"8687_CR81","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1038\/onc.2008.301","volume":"27","author":"DN Dhanasekaran","year":"2008","unstructured":"Dhanasekaran, D. N. & Reddy, E. P. JNK signaling in apoptosis. Oncogene 27, 6245\u20136251. https:\/\/doi.org\/10.1038\/onc.2008.301 (2008).","journal-title":"Oncogene"},{"key":"8687_CR82","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1038\/s41419-017-0053-0","volume":"8","author":"TS Fung","year":"2017","unstructured":"Fung, T. S. & Liu, D. X. Activation of the c-Jun NH2-terminal kinase pathway by coronavirus infectious bronchitis virus promotes apoptosis independently of c-Jun. Cell Death Dis. 8, 3215. https:\/\/doi.org\/10.1038\/s41419-017-0053-0 (2017).","journal-title":"Cell Death Dis."},{"key":"8687_CR83","doi-asserted-by":"publisher","first-page":"11275","DOI":"10.1128\/jvi.75.23.11275-11283.2001","volume":"75","author":"P Clarke","year":"2001","unstructured":"Clarke, P., Meintzer, S. M., Widmann, C., Johnson, G. L. & Tyler, K. L. Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun. J. Virol. 75, 11275\u201311283. https:\/\/doi.org\/10.1128\/jvi.75.23.11275-11283.2001 (2001).","journal-title":"J. Virol."},{"key":"8687_CR84","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1128\/jvi.78.23.13132-13138.2004","volume":"78","author":"P Clarke","year":"2004","unstructured":"Clarke, P. et al. JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells. J. Virol. 78, 13132\u201313138. https:\/\/doi.org\/10.1128\/jvi.78.23.13132-13138.2004 (2004).","journal-title":"J. Virol."},{"key":"8687_CR85","doi-asserted-by":"publisher","first-page":"e1004020","DOI":"10.1371\/journal.ppat.1004020","volume":"10","author":"Y Huang","year":"2014","unstructured":"Huang, Y. et al. MAVS-MKK7-JNK2 defines a novel apoptotic signaling pathway during viral infection. PLoS Pathog. 10, e1004020. https:\/\/doi.org\/10.1371\/journal.ppat.1004020 (2014).","journal-title":"PLoS Pathog."},{"key":"8687_CR86","doi-asserted-by":"publisher","first-page":"29980","DOI":"10.1074\/jbc.M003776200","volume":"275","author":"M Fan","year":"2000","unstructured":"Fan, M. et al. Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1\/MEK\/ERK cascade. J. Biol. Chem. 275, 29980\u201329985. https:\/\/doi.org\/10.1074\/jbc.M003776200 (2000).","journal-title":"J. Biol. Chem."},{"key":"8687_CR87","doi-asserted-by":"publisher","first-page":"12752","DOI":"10.1128\/JVI.02138-14","volume":"88","author":"TS Fung","year":"2014","unstructured":"Fung, T. S., Liao, Y. & Liu, D. X. The Endoplasmic reticulum stress sensor IRE1alpha protects cells from apoptosis induced by the coronavirus infectious bronchitis virus. J. Virol. 88, 12752\u201312764. https:\/\/doi.org\/10.1128\/JVI.02138-14 (2014).","journal-title":"J. Virol."},{"key":"8687_CR88","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s10495-013-0928-1","volume":"19","author":"CR Han","year":"2014","unstructured":"Han, C. R., Jun do, Y., Lee, J. Y. & Kim, Y. H. Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with bak or bim, provoking bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells. Apoptosis 19, 224\u2013240. https:\/\/doi.org\/10.1007\/s10495-013-0928-1 (2014).","journal-title":"Apoptosis"},{"key":"8687_CR89","doi-asserted-by":"publisher","first-page":"682","DOI":"10.18632\/genesandcancer.155","volume":"8","author":"DN Dhanasekaran","year":"2017","unstructured":"Dhanasekaran, D. N. & Reddy, E. P. JNK-signaling: a multiplexing hub in programmed cell death. Genes Cancer. 8, 682\u2013694. https:\/\/doi.org\/10.18632\/genesandcancer.155 (2017).","journal-title":"Genes Cancer"},{"key":"8687_CR90","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1182\/blood.V114.22.2752.2752","volume":"114","author":"A Steele","year":"2009","unstructured":"Steele, A. et al. Induction of Noxa via generation of reactive oxygen species plays a key role in induction of CLL cell apoptosis by two novel p53-Independent cytotoxic agents. Blood 114, 2752. https:\/\/doi.org\/10.1182\/blood.V114.22.2752.2752 (2009).","journal-title":"Blood"},{"key":"8687_CR91","doi-asserted-by":"publisher","unstructured":"Cosolo, A. et al. JNK-dependent cell cycle stalling in G2 promotes survival and senescence-like phenotypes in tissue stress. Elife 8 https:\/\/doi.org\/10.7554\/eLife.41036 (2019).","DOI":"10.7554\/eLife.41036"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08687-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08687-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08687-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:24:30Z","timestamp":1752139470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08687-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8687"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08687-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24624"}}